Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T15:01:50.091Z.
Calculation as of: 2026-10-06T15:01:50.091Z.
Quote observation: 2026-10-06T15:00:14.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 396f74b358d2be52688229160785b883c1ccba5e7e57b4b59ce0869c705c56f9
EARNINGS YIELD
N/A
Market Cap
$403.77M
Earnings Yield
N/A
TTM Avg
1.28%
3Y Avg
2.85%
5Y Avg
3.31%
Market Cap
$410.08M
Earnings Yield
N/A
TTM Avg
8.82%
3Y Avg
5.78%
5Y Avg
5.78%
Market Cap
$416.44M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$392.03M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$384.23M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$384.01M
Earnings Yield
N/A
TTM Avg
1.96%
3Y Avg
1.22%
5Y Avg
1.02%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Carlsmed, Inc. (CARL) | $406.14M | N/A | N/A | N/A | N/A |
| Myriad Genetics, Inc. (MYGN)vs › | $403.77M | N/A | 1.28% | 2.85% | 3.31% |
| Neurogene Inc. (NGNE)vs › | $410.45M | N/A | 5.34% | 5.37% | 5.37% |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $410.08M | N/A | 8.82% | 5.78% | 5.78% |
| Shoulder Innovations, Inc. (SI)vs › | $411.45M | N/A | N/A | N/A | N/A |
| Eikon Therapeutics, Inc. Common Stock (EIKN)vs › | $416.44M | N/A | N/A | N/A | N/A |
| MapLight Therapeutics, Inc. (MPLT)vs › | $392.03M | N/A | N/A | N/A | N/A |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $384.23M | N/A | N/A | N/A | N/A |
| Orthofix Medical Inc. (OFIX)vs › | $384.01M | N/A | 1.96% | 1.22% | 1.02% |
| Editas Medicine, Inc. (EDIT)vs › | $429.68M | N/A | N/A | N/A | N/A |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
